NANOGP8 and neoplasm: We subcutaneously injected 2 × 106NANOG1-knockout cells, NANOGP8-knockout cells, or parental cells into non-obese diabetic/severe combined immunodeficient (NOD-SCID) mice to determine whether NANOG depletion influences tumor development in vivo.